Since 2007, JonesTrading has offered public companies an alternative vehicle for financing and investment banking through direct access to the investor community. JonesTrading believes corporations have been underserved by the offerings currently available.
GHI Greystone Housing Impact Investors LP
$50,000,000
At-the-Market
Sales Agent | March 2024
CATX Perspective Therapeutics Inc
$87,400,000
Private Placement
Co-Placement Agent | March 2024
ACHV Achieve Life Sciences
$124,200,000
Registered Direct
Joint Placement Agent | February 2024
MEIP MEI Pharma Inc
$9,900,000
At-the-Market
Sole Sales Agent | February 2024
ATHE Alterity Therapeutics
$6,000,000
At-the-Market
Sole Sales Agent | February 2024
PCN PIMCO
$275,000,000
PCN - At-the-Market
Sole Sales Agent | February 2024
PFL PIMCO
$100,000,000
PFL - At-the-Market
Sole Sales Agent | February 2024
CRIS Curis Inc
$100,000,000
At-the-Market
Sales Agent | February 2024
ACET Adicet Bio Inc
$19,300,000
ATM Block Trade
Sole Sales Agent | January 2024
CALC CalciMedica
$54,000,000
Private Placement
Sole Placement Agent | January 2024
OCUP Ocuphire Pharma
$40,000,000
At-the-Market
Sole Sales Agent | January 2024
NMTC NeuroOne Technologies Corp
$9,300,000
At-the-Market
Sole Sales Agent | January 2024
ALCE Clean Earth Acquisitions Corp
Alternus Clean Energy
SPAC Merger
Financial Advisor | December 2023
HRTG Heritage Insurance Holdings Inc
$25,000,000
Follow-On
Sole Book-Runner | December 2023
CATX Perspective Therapeutics Inc
$50,000,000
At-the-Market
Sales Agent | November 2023
Pimco
$2,000,000,000
PDI - At-the-Market
Sole Sales Agent | September 2023
Pimco
$750,000,000
PTY - At-the-Market
Sole Sales Agent | September 2023
EQT EQT Corp
$828,000,000
Block Trade
Sole Agent | September 2023
DAWN Day One Biopharmaceuticals
$250,000,000
At-the-Market
Sales Agent | September 2023
VFS VinFast Auto Ltd
$23,000,000,000
SPAC Merger
Financial Advisor | August 2023
ATNM Actinium Pharmaceuticals
$200,000,000
At-the-Market
Sales Agent | August 2023
ARR Armour Residential REIT
75,000,000 shares
At-the-Market
Sales Agent | July 2023
VIRI Virios Therapeutics
$6,700,000
At-the-Market
Sole Sales Agent | July 2023
DAWN Day One Pharmaceuticals
$150,000,000
Follow-On
Co-Manager | June 2023
SAVA Cassava Sciences, Inc
$200,000,000
At-the-Market
May 2023
BRTX BioRestorative Therapies Inc
$3,700,000
At-the-Market
Sole Sales Agent | April 2023
FBRT Franklin Realty Trust Inc
$200,000,000
At-the-Market
Sales Agent | April 2023
ORC Orchid Island Capital Inc
$250,000,000
At-the-Market
Sales Agent | March 2023
IVR Invesco Mortgage Capital Inc
16,000,000 shares
At-the-Market
Sales Agent | February 2023
DX Dynex Capital Inc
36,117,622 shares
At-the-Market
Sales Agent | February 2023
PIMCO
$500,000,000
PDO - At-the-Market
Sole Sales Agent | February 2023
WULF Terawulf
$25,000,000
Follow-On
Sole Book-Runner | February 2023
PIMCO
$100,000,000
PCN At-the-Market
Sole Sales Agent | January 2023
ISRL Israel Acquisitions Corp.
$125,000,000
ISRL - IPO
Co-Manager | January 2023
MNPR Monopar Therapeutics
$6,505,642
At-the-Market
Sole Sales Agent | January 2023
NMTC NeuroOne Medical Technologies Corp.
$14,500,000
At-the-Market
Sole Sales Agent | December 2022
APTO Aptose Biosciences
$50,000,000
At-the-Market
Sole Sales Agent | December 2022
HIX Western Asset
$143,970,507
At-the-Market
Sole Sales Agent | December 2022
CTO Realty Growth
3,000,000 shares
Follow-On
Co-Manager | November 2022
SAVA Cassava Sciences
$50,000,000
Registered Direct
Capital Markets Advisor | November 2022
TFFP TFF Pharmaceuticals Inc.
$10,675,000
Follow-On
Sole Book-Runner | November 2022
ACET Adicet Bio
$100,000,000
At-the-Market
Sole Sales Agent | November 2022
RAIN Rain Therapeutics Inc.
$50,000,000
Registered Direct
Lead Manager | November 2022
Bullhorn Holdings
Coeptis Therapeutics
$175,000,000
M&A Transaction
Capital Markets Advisor | October 2022
CTO Realty Growth
$150,000,000
At-the-Market
Sales Agent | October 2022
PINE Alpine Income Property Trust
$150,000,000
At-the-Market
Sales Agent | October 2022
EVAX Evaxion Biotech
$14,439,000
At-the-Market
Sole Sales Agent | October 2022
HCWB HCW Biologics
$15,500,000
At-the-Market
Sole Sales Agent | August 2022
UNCY Unicycive Therapeutics
$3,000,000
At-the-Market
Sole Sales Agent | August 2022
PIMCO
$225,000,000
PML - At-the-Market
Sole Sales Agent | August 2022
ACET ADICET BIO
$45,000,000
ATM Direct Transaction
PIMCO
$1,000,000,000
PDI - At-the-Market
Sole Sales Agent | June 2022
DAWN Day One Biopharmaceuticals
$150,000,000
At-the-Market
Sales Agent | June 2022
PIMCO
$200,000,000
PHK - At-the-Market
Sole Sales Agent | June 2022
SIEB Siebert Financial Corp.
$9,600,000
At-the-Market
Sole Sales Agent | May 2022
BOXD Boxed Inc.
$100,000,000
Committed Capital
On-Demand | May 2022
AGLE Aeglea BioTherapeutic
$45,000,000
Registered Direct
Sole Placement Agent | May 2022
CRNX Crinetics Pharmaceuticals
$125,000,000
Follow-On
Co-Manager | April 2022
Clean Earth Acquisitions Corp.
$200,000,000
CLIN - IPO
Co-Manager | February 2022
Cohen & Steers
$305,000,000
RLTY - IPO
Co-Manager | February 2022
EFC Ellington Financial
$100,000,000
Preferred ATM
Sales Agent | January 2022
ACER Acer Therapeutics
$6,850,000
At-the-Market
Sales Agent | December 2021
BOXD Boxed, Inc
$120,000,000
SPAC PIPE & Merger
Placement Agent & Advisor | December 2021
ACET Adicet Bio
$87,500,000
Follow-on
Co-Manager | December 2021
Infint Acquisition Corp
$173,912,000
INFIN - IPO
Joint Book-Runner | November 2021
Credit Suisse
$150,000,000
CIK-At-the-Market
Sole Sales Agent | November 2021
MITT AG Mortgage Investment Trust
$71,750,000
Follow-On
Co-Manager | November 2021
CBAY CymaBay Therapeutics
$75,000,000
Follow-On
Co-Lead Manager | November 2021
ARR Armour Residendial REIT
25,661,843 shares
At-the-Market
Sales Agent | November 2021
IVR Invesco Mortgage Capital, Inc.
$236,250,000
At-the-Market
Sales Agent | November 2021
MEGI CBRE Group Inc.
50,000,000 shares
MEGI-IPO
Co-Manager | October 2021
CNRX Crinetics Pharmaceuticals
$150,000,000
Follow-On
Co-Manager | October 2021
ACR Acres Commercial Realty
2,200,000 shares
Preferred ATM
Sole Sales Agent | October 2021
ECAT BlackRock Inc.
$2,040,000,000
ECAT-IPO
Co-Manager | September 2021
ATAX America First Multifamily Investors, L.P.
$28,975,000
Follow-On
Co-Manager | September 2021
Aberdeen Asset Management
$35,000,000
FCO-At-the-Market
Sole Sales Agent | September 2021
SWSS Springwater Capital
$150,000,000
IPO
Co-Manager | August 2021
NYMT New York Mortgage Trust Inc
$100,000,000
Preferred ATM
Sole Sales Agent | August 2021
SURF Surface Oncology
$80,000,000
At-the-Market
Sole Sales Agent | August 2021
INFI Infinity Pharmaceuticals
$75,000,000
At-the-Market
Sales Agent | July 2021
ATAX America First Multifamily Investors, L.P.
$30,000,000
At-the-Market
Sole Sales Agent | July 2021
BSAQU Black Spade Capital
$150,000,000
IPO
Co-Manager | July 2021
AAIC Arlington
$33,500,000
6% Senior Notes
Co-Manager | July 2021
GEO GEO Group, Inc
$300,000,000
At-the-Market
Sales Agent | June 2021
ORC Orchid Island Capital
$250,000,000
At-the-Market
Sales Agent | June 2021
FEMY Femasys
$34,450,000
IPO
Joint Bookrunner | June 2021
IKT Inhibikase Therapeutics Inc.
$45,000,000
Follow-on
Co-Manager | June 2021
IVR Invesco Mortgage Capital, Inc.
37,500,000 shares
Follow-on
Joint Bookrunner | May 2021
NBXG Neuberger Berman
$1,500,000,000
NBXG - IPO
Co-Manager | May 2021
DMO Western Asset
$43,283,467
DMO-At-the-Market
Sole Sales Agent | May 2021
ALDX Aldeyra
$125,000,000
Follow-on
Co-Manager | April 2021
LFT Lument Finance Trust
$60,000,000
pfd. Follow-on
Co-Manager | April 2021
NUV Nuveen
$575,000,000
NPCT - IPO
Co-Manager | April 2021
VBLT VBL Therapeutics
$25,080,504
Follow-on
Co-Manager | April 2021
BlackRock Inc.
$4,400,000,000
BIGZ - IPO
Co-Manager | March 2021
AVEO Aveo Pharmaceuticals, Inc.
$48,000,000
Follow-On
Co-Manager | March 2021
LIFE aTyr Pharmaceuticals
$25,000,000
At-the-Market
Sole Sales Agent | March 2021
OPA-UN Magnum Opus Acquisition Ltd.
$200,000,000
IPO
Co-Manager | March 2021
CRIS Curis Inc.
$100,000,000
At-the-Market
Sales Agent | March 2021
ACET Adicet Bio
$75,000,000
At-the-Market
Sole Sales Agent | March 2021
OCUP Ocuphire Pharma Inc.
$40,000,000
At-the-Market
Sole Sales Agent | March 2021
ACER Acer Therapeutics
$7,7000,000
At-the-Market
Sales Agent | March 2021
XA Investments
$25,000,000
XFLT - Follow-On
Co-Manager | February 2021
RiverNorth
$440,000,000
RFMZ - IPO
Co-Manager | February 2021
INFI Infinity Pharmaceuticals
$79,800,000
Follow-On
Co-Manager | February 2021
CNSP CNS Pharmaceuticals
$20,000,000
At-the-Market
Sales Agent | February 2021
DX Dynex Capital Inc.
$49,087,500
Follow-On
Co-Manager | January 2021
ALRN Aileron
$30,000,000
At-the-Market
Sales Agent | January 2021
Pimco
$2,000,000,000
PDO - IPO
Co-Manager | January 2021
CMRX Chimerix
$100,000,000
Follow-On
Co-Manager | January 2021
CMO Capstead Mortgage Corp
15,000,000 Common
3,000,000 PFD
At-the-Market
Sales Agent | January 2021
ALRN Aileron Therapeutics Inc.
$35,894,080
Registered Direct
Placement Agent
January 2021
ALRN Aileron Therapeutics Inc.
$11,896,613
At-the-Market
Sole Sales Agent
December 2020
SVOKU Seven Oaks Acquisition Corp
$258,750,000
IPO
Lead Bookrunner
December 2020
ATHE Alterity Therapeutics
$50,000,000
At-the-Market
Sales Agent
December 2020
TCON Tracon Pharmaceuticals Inc.
$50,000,000
At-the-Market
Sole Sales Agent
December 2020
CRIS Curis Inc.
$170,000,000
Follow-On
Joint Bookrunner
December 2020
Pimco
$100,000,000
PCN - At-the-Market
Sole Sales Agent
December 2020
Pimco
$175,000,000
PFN - At-the-Market
Sole Sales Agent
November 2020
Pimco
$120,000,000
PFL - At-the-Market
Sole Sales Agent
November 2020
PGIM
23,750,000 shares
SDHY - IPO
Co-Manager
November 2020
Pimco
$600,000,000
PTY - At-the-Market
Sole Sales Agent
November 2020
Pimco
$600,000,000
PDI - At-the-Market
Sole Sales Agent
November 2020
Cohen & Steers
50,000,000 shares
PTA - IPO
Co-Manager
October 2020
Pimco
$125,000,000
PKO - At-the-Market
Sole Sales Agent
October 2020
Pimco
$1,000,000,000
PCI - At-the-Market
Sole Sales Agent
October 2020
Pimco
4,312,500 shares
PDI - Follow-On
Co-Manager
October 2020
BlackRock, Inc
100,000,000 shares
BCAT - IPO
Co-Manager
September 2020
nuveen
52,000,000 shares
NDMO - IPO
August 2020
ATNM Actinium Pharmaceuticals, Inc.
$200,000,000
At-the-Market
Sole Sales Agent
August 2020
DX Dynex Capital Inc.
$50,000,000
Preferred ATM
Sales Agent
August 2020
ORC Orchid Island Capital Inc.
$150,000,000
At-the-Market
Sales Agent
August 2020
Aberdeen Asset Management
8,850,000 shares
ASGI - IPO
Co-Manager
July 2020
ABIO Arca Biopharma
$54,000,000
At-the-Market
Sole Sales Agent
July 2020
ABIO Arca Biopharma
$14,910,600
At-the-Market
Sole Sales Agent
July 2020
OSTK Overstock
$150,000,000
At-the-Market
Sales Agent
June 2020
First Trust
33,250,000 shares
FTHY - IPO
Co-Manager
June 2020
Angel Oak Capital Advisors
4,050,000 shares
DYFN - IPO
June 2020
CBIO Catalyst Biosciences
$30,000,000
Follow-On
Co-Manager
June 2020
CBIO Catalyst Biosciences
4,615,385 shares
Co-Manager
Follow-On | June 2020
ATNM Actinium Pharmaceuticals, Inc
$24,997,873
Co-Manager
Follow-On | June 2020
CRIS Curis
14,000,000 shares
Registered Direct
June 2020
ABIO Arca Biopharma
$6,061,175
Registered Direct
June 2020
SURF Surface Oncology
$50,000,000
ATM Follow-On
May 2020
SURF Surface Oncology
$28,900,000
ATM Block Trade
May 2020
AGLE Aeglea Biotherapeutics Inc
$119,998,639
Co-Manager
Follow-On | April 2020
ATNM Actinium Pharmaceuticals, Inc
$27,491,750
Co-Manager
Follow-On | April 2020
DMO Western Asset
$50,000,000
ATM Follow-On
April 2020
AGLE Aeglea Biotherapeutics Inc
$60,000,000
ATM Follow-On
April 2020
OSTK Overstock
$80,000,000
ATM Follow-On
April 2020
RFM River North
5,500,000 shares
Initial Public Offering
March 2020
PFL Pimco
$47,700,000
ATM Follow-On
March 2020
PFN Pimco
$76,800,000
ATM Follow-On
March 2020
ACER Acer Therapeutics
$10,000,000
ATM Follow-On
March 2020
CRIS Curis
$30,000,000
ATM Follow-On
March 2020
TCON Tracon Pharma
$1,983,015
ATM Follow-On
February 2020
DLY DoubleLine Funds
46,000,000 shares
Initial Public Offering
February 2020
DX Dynex Capital, Inc.
4,000,000 shares
Preferred New Issue
February 2020
CBIO Catalyst Biosciences
4,615,385 shares
Follow-On | February 2020
IVR Invesco Mortgage Capital Inc.
18,000,000 shares
Co-Manager
Follow-On | February 2020
BMEZ BlackRock
105,000,000 shares
Sole Placement Agent
Initial Public Offering | January 2020
PKO Pimco
$125,000,000
ATM Follow-On
January 2020
ORC Orchid Island Capital
$200,000,000
ATM Follow-On
January 2020
MNPR Monopar Therapeutics
$19,700,000
ATM Follow-On
January 2020
MRTX Mirati Therapeutics
$300,000,000
Co-Manager Follow-On
January 2020
MNPR Monopar Therapeutics
1,111,112 shares
Sole Bookrunner
Initial Public Offering
December 2019
APTO Aptose Biosciences
16,125,000 shares
Co-Manager Follow-On
December 2019
FTSV Forty Seven Inc
4,860,000 shares
Co-Manager Follow-On
December 2019
PCI Pimco
$1,000,000,000
ATM Follow-On
December 2019
HIE Miller Howard Investments
$50,000,000
ATM Follow-On
December 2019
PTY Pimco
$500,000,000
ATM Follow-On
November 2019
PFL Pimco
5,500,000 shares
ATM Follow-On
November 2019
CPZ Calamos Investments
18,250,000 shares
Initial Public Offering
November 2019
PFN Pimco
11,500,000 shares
ATM Follow-On
November 2019
NYMT New York Mortgage Trust
$100,000,000
Preferred ATM
Series B, C, D & E
November 2019
OSTK Overstock
$150,000,000
ATM Follow-On
November 2019
PDI Pimco
$560,000,000
ATM Follow-On
November 2019
PKO Pimco
3,000,000 shares
ATM Follow-On
October 2019
AIO Allianz
30,750,000 shares
Initial Public Offering
October 2019
NMCO Nuveen
Initial Public Offering
September 2019
RMM RiverNorth
18,250,000 shares
Initial Public Offering
July 2019
PTY Pimco
$500,000,000
ATM Follow-On | July 2019
ALRN Aileron
$13,265,506
Sole Placement Agent
ATM Follow-On | July 2019
INFI Infinity Pharmaceuticals
$20,000,000
ATM Follow-On | June 2019
FBIO Fortress Biotech
$50,000,000
ATM Follow-On | June 2019
BSTZ BlackRock
70,000,000 shares
Co-Manager
Initial Public Offering | June 2019
ARQL ArQule
9,250,000 shares
Co-Manager
ATM Follow-On | June 2019
APTS Preferred Apartment Communities
$125,000,000
ATM Follow-On | June 2019
DX Dynex Capital Inc.
25,000,000 shares
ATM Follow-On | May 2019
APTO Aptose Biosciences
10,000,000 shares
Co-Manager
Follow-On | May 2019
FINS Angel Oak Capital Advisors
10,750,000 shares
Initial Public Offering | May 2019
TRMT Tremont Mortgage Trust
5,000,000 shares
Co-Manager
Follow-On | May 2019
BPMX BioPharmx
$8,500,000
ATM Follow-On | May 2019
SURF Surface Oncology
$30,000,000
ATM Follow-On | May 2019
Sharebite
$3,000,000
Sole Placement Agent
Series A Financing | May 2019
ATNM Actinium Pharmaceuticals
42,860,000 shares
Co-Manager
Follow-On | April 2019
NYMT New York Mortgage Trust
$50,000,000
Preferred ATM
Series B, C & D | March 2019
TEAF Tortoise
13,000,000 shares
Initial Public Offering
March 2019
AI Arlington
1,647,370 shares
Preferred ATM
Series B | March 2019
IVR Invesco Mortgage Capital
7,000,000 shares
Preferred ATM
Series A, B & C | March 2019
OSTK Overstock
$52,801,423
ATM Follow-On | March 2019
AI Arlington
1,200,000 shares
Co-Manager
Preferred New Issue | March 2019
AI Arlington
6,000,000 shares
Co-Manager
Follow-On | February 2019
NRGX Pimco
40,000,000 shares
Initial Public Offering
January 2019
ABIO ARCA biopharma
$2,499,876
ATM Follow-On | January 2019
ATNM Actinium Pharmaceuticals
75,000,000 shares
ATM Follow-On | December 2018
JHAA Nuveen
Initial Public Offering
December 2018
CLSN Celsion Corporation
$16,000,000
ATM Follow-On | December 2018
PTY Pimco
14,500,000 shares
ATM Follow-On | November 2018
agbiotic
$5,000,000
Sole Placement Agent
Series A Financing | October 2018
VSTM Verastem Oncology
$150,000,000
Co-Manager
Convertible Sr. Notes | October 2018
REIT Select Income
24,918,421 shares
Co-Manager
Secondary Sale | October 2018
ALDX Aldeyra Therapeutics
5,250,000 shares
Co-Manager
Follow-On | September 2018
PFL Pimco
5,500,000 shares
ATM Follow-On | September 2018
PFN Pimco
11,500,000 shares
ATM Follow-On | September 2018
TCON Tracon Pharmaceuticals
$11,550,332
ATM Follow-On | September 2018
DX Dynex Capital
$50,000,000
Preferred ATM | September 2018
RIV RiverNorth
3,300,000 shares
ATM Follow-On | August 2018
SDI Standard Diversified
$6,500,000
ATM Follow-On | August 2018
OSTK Overstock
$150,000,000
ATM Follow-On | August 2018
ATAX America First Multifamily Investors, L.P.
$75,000,000
ATM Follow-On | August 2018
ARQL ArQule
12,650,000 shares
Co-Manager
ATM Follow-On | July 2018
PKO Pimco
3,000,000 shares
ATM Follow-On | July 2018
CGO Calamos
2,685,638 shares
ATM Follow-On | June 2018
PTY Pimco
14,500,000 shares
ATM Follow-On | June 2018
TTOO T2 Biosystems
7,015,000 shares
Co-Manager
Follow-On | May 2018
AGLE Aeglea Biotherapeutics
4,500,000 shares
Lead Manager
Follow-On | April 2018
ONVO Organovo
$50,000,000
ATM Follow-On | March 2018
FPL First Trust
5,000,000 shares
ATM Follow-On | March 2018
FEI First Trust
4,600,000 shares
ATM Follow-On | March 2018
FEN First Trust
2,800,000 shares
ATM Follow-On | March 2018
HIE Miller Howard Investments
$50,000,000
ATM Follow-On | March 2018
CHY Calamos
6,232,167 shares
ATM Follow-On | March 2018
DHY Credit Suisse
16,690,564 shares
ATM Follow-On | February 2018
CBIO Catalyst Biosciences
$115,500,000
Follow-On Offering
Sole Bookrunning Manager | February 2018
PTIE Pain Therapeutics, Inc
$16,900,000
ATM Follow-On | February 2018
ILPT Industrial Logistics Property Trust
20,000,000 shares
Underwriter
IPO | January 2018
CBIO Catalyst Biosciences
$10,500,000
Follow-On Offering
Joint Book-Runner | December 2017
PDI Pimco
9,500,000 shares
ATM Follow-On | December 2017
ATAX America First Multifamily Investors, L.P.
$75,000,000
ATM Follow-On | December 2017
PRAN Prana Biotechnology
$10,019,412
ATM Follow-On | November 2017
HIE Miller Howard Investments
$50,000,000
ATM Follow-On | October 2017
ABEO Abeona Therapeutics
5,000,000 shares
Follow-On Offering
Co-Manager | October 2017
CHY Calamos
6,232,167 shares
ATM Follow-On | October 2017
CHI Calamos
7,500,000 shares
ATM Follow-On | October 2017
TTOO T2 Biosystems
4,375,000 shares
Follow-On
Co-Manager | September 2017
IRT Independence Realty Trust
12,500,000 shares
Follow-On
Co-Manager | September 2017
ABIO ARCA biopharma
$3,568,486
ATM Follow-On | August 2017
OMER Omeros Corp
3,000,000 shares
Co-Manager
Follow-On | August 2017
ATNM Actinum Pharmaceuticals
$16,125,000
Follow-On
Co-Manager | July 2017
DHY Credit Suisse
20,000,000 shares
ATM Follow-On | July 2017
APTS Preferred Apartment Communities
$150,000,000
ATM Follow-On | July 2017
FPL First Trust
5,000,000
ATM Follow-On | July 2017
ATNM Actinum Pharmaceuticals
$75,000,000
ATM Follow-On | July 2017
GOV Government Properties Income Trust
25,000,000 shares
Follow-On Offering
Co-Manager | June 2017
FEN First Trust
2,800,000 shares
ATM Follow-On | June 2017
FEI First Trust
4,600,000 shares
ATM Follow-On | June 2017
AGLE Aeglea Biotherapeutics
3,000,000 shares
Follow-On Offering
Sole Book-Runner | June 2017
AI Arlington Asset Investment Corp
1,865,000 shares
Preferred ATM, Series B | May 2017
APTS Preferred Apartment Communities
$48,000,000
Follow-On Offering
Co-Lead Manager | May 2017
AI Arlington Asset Investment Corp
135,000 shares
Series B Pref.
New Issue | May 2017
AGLE Aeglea Biotherapeutics
$20,000,000
ATM Follow-On | May 2017
HT Hersha Hospitality Trust
8,000,000 shares
Class A, Series E + D Pfd
ATM Follow-On | April 2017
PDI Pimco
9,500,000 shares
ATM Follow-On | March 2017
PTY Pimco
14,500,000 shares
ATM Follow-On | March 2017
CBIO Catalyst Biosciences
$115,000,000
Follow-On Offering
Sole Bookrunning Manager | February 2018
AI Arlington Asset Investment Corp
6,000,000 shares
ATM Follow-On | February 2017
Medley Capital Corporation
$34,500,000
Baby Bond
Joint Book-Runner | February 2017
CBAY CymaBay Therapeutics
5,181,348 shares
Follow-On Offering
Sole Book-Runner | February 2017
Medley Capital Corporation
$34,500,000
Baby Bond
Joint Book-Runner | February 2017
ABIO ARCA biopharma
$7,300,000
ATM Follow-On | January 2017